These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31627288)

  • 1. Modulating Immune Response with Nucleic Acid Nanoparticles.
    Durbin JK; Miller DK; Niekamp J; Khisamutdinov EF
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31627288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and Composition Define Immunorecognition of Nucleic Acid Nanoparticles.
    Hong E; Halman JR; Shah AB; Khisamutdinov EF; Dobrovolskaia MA; Afonin KA
    Nano Lett; 2018 Jul; 18(7):4309-4321. PubMed ID: 29894623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology.
    Panigaj M; Johnson MB; Ke W; McMillan J; Goncharova EA; Chandler M; Afonin KA
    ACS Nano; 2019 Nov; 13(11):12301-12321. PubMed ID: 31664817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunorecognition, subcellular compartmentalization, and physicochemical properties of nucleic acid nanoparticles can be controlled by composition modification.
    Johnson MB; Halman JR; Miller DK; Cooper JS; Khisamutdinov EF; Marriott I; Afonin KA
    Nucleic Acids Res; 2020 Nov; 48(20):11785-11798. PubMed ID: 33091133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostimulation of Fibrous Nucleic Acid Nanoparticles Can be Modulated through Aptamer-Based Functional Moieties: Unveiling the Structure-Activity Relationship and Mechanistic Insights.
    Rebolledo LP; Ke W; Cedrone E; Wang J; Majithia K; Johnson MB; Dokholyan NV; Dobrovolskaia MA; Afonin KA
    ACS Appl Mater Interfaces; 2024 Feb; 16(7):8430-8441. PubMed ID: 38344840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Break to Build: Isothermal Assembly of Nucleic Acid Nanoparticles (NANPs)
    Beasock D; Ha A; Halman J; Panigaj M; Wang J; Dokholyan NV; Afonin KA
    Bioconjug Chem; 2023 Jun; 34(6):1139-1146. PubMed ID: 37293781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of Spherical Nucleic Acid Nanoparticles as Delivery Systems.
    Mokhtarzadeh A; Vahidnezhad H; Youssefian L; Mosafer J; Baradaran B; Uitto J
    Trends Mol Med; 2019 Dec; 25(12):1066-1079. PubMed ID: 31703931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of methods in RNA nanotechnology: synthesis, purification, and characterization of RNA nanoparticles.
    Haque F; Guo P
    Methods Mol Biol; 2015; 1297():1-19. PubMed ID: 25895992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects.
    Johnson MB; Chandler M; Afonin KA
    Adv Drug Deliv Rev; 2021 Jun; 173():427-438. PubMed ID: 33857556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Intracellular Compartmentalization of RNA Nanostructures.
    Radwan Y; Afonin KA; Johnson MB
    Methods Mol Biol; 2023; 2709():211-228. PubMed ID: 37572283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation.
    Afonin KA; Dobrovolskaia MA; Ke W; Grodzinski P; Bathe M
    Adv Drug Deliv Rev; 2022 Feb; 181():114081. PubMed ID: 34915069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Recognition of and Reactions to Nucleic Acid Nanoparticles by Human Immune Cells.
    Bila D; Radwan Y; Dobrovolskaia MA; Panigaj M; Afonin KA
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies.
    Dobrovolskaia MA
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31861154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs).
    Chandler M; Johnson MB; Panigaj M; Afonin KA
    Curr Opin Biotechnol; 2020 Jun; 63():8-15. PubMed ID: 31778882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting Functional Biological Interactions Using Modular RNA Nanoparticles.
    Klotz K; Radwan Y; Chakrabarti K
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-throughput screening assay for the functional delivery of splice-switching oligonucleotides in human melanoma cells.
    Dean JM; DeLong RK
    Methods Mol Biol; 2015; 1297():187-96. PubMed ID: 25896004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart-Responsive Nucleic Acid Nanoparticles (NANPs) with the Potential to Modulate Immune Behavior.
    Chandler M; Afonin KA
    Nanomaterials (Basel); 2019 Apr; 9(4):. PubMed ID: 31013847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembled nucleic acid nanoparticles capable of controlled disassembly in response to a single nucleotide mismatch.
    Kim J; Im CA; Jung Y; Qazi A; Shin JS
    Biomacromolecules; 2010 Jul; 11(7):1705-9. PubMed ID: 20527811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells.
    Hong E; Halman JR; Shah A; Cedrone E; Truong N; Afonin KA; Dobrovolskaia MA
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30897721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods and assays for specific targeting and delivery of RNA nanoparticles to cancer metastases.
    Rychahou P; Shu Y; Haque F; Hu J; Guo P; Evers BM
    Methods Mol Biol; 2015; 1297():121-35. PubMed ID: 25896000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.